Skip to main content
. 2021 Jul 28;16:330. doi: 10.1186/s13023-021-01961-8

Table 1.

Study group characteristics

SMA (n = 79) Controls (n = 30)
Age (year), median (IQR) 31 (17–43) 30 (17–44)
Age of onset (year), median (IQR) 1 (0–3)
Disease duration (year), median (IQR) 28 (15–37)
Sex, n (%)
 Female 41 (52) 18 (60)
 Male 38 (48) 12 (40)
SMA type, n (%)
 1 7 (9)
 2 33 (42)
 3 39 (49)
SMN2 copy number, n (%)
 2 9 (16)
 3 31 (53)
 4+ 18 (31)
 Unknown 21
Weight (kg), median (IQR) 50 (33–65)
Height (cm), median (IQR) 158 (145–170)
BMI (kg/m2), median (IQR) 20.5 (16.1–23.4)
Scoliosis, n (%)
 Present 50 (63)
 Not present 29 (37)
Spondylodesis, n (%)
 Present 24 (30)
 Not present 55 (70)
CT supported LP, n (%)
 Yes 44 (56)
 No 35 (44)
Use of a-/traumatic needle, n (%)
 Traumatic 37 (47)
 Atraumatic 42 (53)
Wheelchair-use, n (%)
 Never 9 (11)
 Occasionally 6 (8)
 Permanently 64 (81)
Mobility, n (%)
 Never able to walk 40 (51)
 Lost ability to walk 24 (30)
 Still able to walk 15 (19)
Ventilation-use, n (%)
 Never 55 (70)
 < 16 h 20 (25)
 > 16 h 4 (5)
PEG/feeding tube, n (%)
 Yes 9 (11)
 No 70 (89)

IQR interquartile range, BMI body mass index, CT computed tomography, LP lumbar puncture, PEG percutaneous endoscopic gastrostomy